Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Study summary

RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.

Ask AI to explain this study

Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiednicotine and Usual Care

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 15, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Eastern Cooperative Oncology Group

Study sponsor

Study overview

What this study is about

Purpose: Other
Study type: Interventional
Phase: Not applicable
Sponsor: Eastern Cooperative Oncology Group
Interventions being studied: Drug: nicotine; Behavioral: Usual Care

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Early-stage or resectable→

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

DISEASE CHARACTERISTICS:
One of the following diagnoses:
Stage I or II bladder, colorectal, head and neck, lung, or other cancer
Stage I-III testicular cancer
Stage I-IV breast cancer, prostate cancer, or lymphoma
Must have smoked 1 or more cigarettes within the past month or define self as a smoker
Hormone receptor status:
Not specified PATIENT CHARACTERISTICS: Age:
19 and over Sex:
Not specified Menopausal status:
Not specified Performance status:
ECOG 0-1 Life expectancy:
Not specified Hematopoietic:
Not specified Hepatic:
Not specified Renal:
Not specified Cardiovascular:
No history of recent heart attack Other:
Not pregnant
No other imminent medical needs requiring referral to a more intensive smoking cessation regimen PRIOR CONCURRENT THERAPY: Biologic therapy:
Not specified Chemotherapy:
Not specified Endocrine therapy:
Not specified Radiotherapy:
Not specified Surgery:
Not specified Other:
No prior participation in the pilot phase study

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Fox Chase Cancer CenterPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 15, 2023. Always confirm current availability with the study team.

View original record ↗